<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="editorial">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">TYSKYGNRymhZZKQswf8W6bf</article-id>
      <article-id pub-id-type="other">00011</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2005001800011</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(05)08500511</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2005001800011</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Pontos de Vista</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cuidando da hipertens&#227;o no consult&#243;rio</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Jardim</surname>
            <given-names>Paulo C&#233;sar B. Veiga</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Goi&#226;nia</named-content>
          <named-content content-type="state">GO</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de Goi&#225;s</institution>
        <institution content-type="orgdiv1">Faculdade de Medicina </institution>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>11</month>
        <year>2005</year>
      </pub-date>
      <volume>85</volume>
      <issue>5</issue>
      <fpage>348</fpage>
      <lpage>349</lpage>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <pub-date publication-format="electronic" date-type="pub">
        <day>05</day>
        <month>12</month>
        <year>2005</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>PONTO DE VISTA</bold>
    </p>
    <p>Cuidando da hipertens&#227;o no consult&#243;rio</p>
    <p>
      <bold>Paulo C&#233;sar B. Veiga Jardim</bold>
    </p>
    <p>Faculdade de Medicina da Universidade Federal de Goi&#225;s - Goi&#226;nia, GO</p>
    <p>
      <xref ref-type="corresp" rid="back10">Endere&#231;o para correspond&#234;ncia</xref>
    </p>
    <p>Receber no consult&#243;rio um paciente portador de hipertens&#227;o arterial e fazer ou confirmar seu diagn&#243;stico &#233; estabelecer um conv&#237;vio que se espera duradouro, pois isso vai significar um bom cuidado e uma boa rela&#231;&#227;o m&#233;dico-paciente<sup>1,2</sup>.</p>
    <p>A cumplicidade do m&#233;dico com seu paciente &#233; o primeiro passo a ser dado, e &#233; absolutamente imprescind&#237;vel para o sucesso de qualquer tratamento. Essa parceria deve se concretizar desde o primeiro momento, e cabe a n&#243;s, sabedores dessa necessidade, caminharmos em dire&#231;&#227;o a este objetivo<sup>1,2</sup>.</p>
    <p>Saber ouvir e ouvir muito. Interessar-nos por cada detalhe da vida desse novo parceiro. Compreender o seu dia a dia, conhecer seus h&#225;bitos, inteirar-nos dos seus anseios e ang&#250;stias, valorizar suas informa&#231;&#245;es<sup>1,2</sup>.</p>
    <p>A aceita&#231;&#227;o de uma "doen&#231;a" n&#227;o &#233; autom&#225;tica. Isso se torna mais complicado quando a altera&#231;&#227;o surge em fase precoce da vida; na maioria das vezes n&#227;o causa sintomas e seu tratamento vai obrigar a modifica&#231;&#245;es no cotidiano da pessoa.</p>
    <p>O segundo passo &#233; a informa&#231;&#227;o. Devemos ser claros, simples e repetitivos, tendo em mente que s&#243; ouvimos o que nos interessa. &#201;, portanto, necess&#225;rio repetir e repetir, de maneiras diferentes, sempre e mais. Um paciente bem informado tem melhores condi&#231;&#245;es de assumir o tratamento. A informa&#231;&#227;o &#233; nossa total responsabilidade, deve ser verbal, escrita e visual<sup>1-3</sup><bold>.</bold> Nunca deve ter fim.</p>
    <p>O terceiro passo, t&#227;o importante quanto os j&#225; descritos, &#233; a disponibilidade. Nada melhor que o contato f&#225;cil, a possibilidade do esclarecimento de uma d&#250;vida, o suporte num momento de inseguran&#231;a. Um telefone para apoio, um endere&#231;o de refer&#234;ncia sempre acess&#237;vel e, nos &#250;ltimos tempos, um e-mail<sup>1-6</sup>.</p>
    <p>&#201; muito rara a hipertens&#227;o isolada, quase sempre h&#225; alguma associa&#231;&#227;o de fatores de risco. Enquanto investigamos a enfermidade, j&#225; devemos iniciar as negocia&#231;&#245;es para a ado&#231;&#227;o de h&#225;bitos de vida saud&#225;veis<sup>4-6</sup>. Afinal, a vida &#233; feita de trocas.</p>
    <p>Seja incisivo, mas n&#227;o inflex&#237;vel, negocie sempre, saiba avan&#231;ar e retroceder quando necess&#225;rio. Estaremos sempre interferindo em h&#225;bitos que fazem parte da cultura da pessoa, sua modifica&#231;&#227;o demanda tempo. Tempo, informa&#231;&#227;o e negocia&#231;&#227;o.</p>
    <p>Cada vez mais temos a convic&#231;&#227;o de que n&#227;o basta tratar os n&#250;meros; hipertens&#227;o &#233; bem mais que isso. O benef&#237;cio ser&#225; t&#227;o maior quanto mais abrangentes formos em nossa a&#231;&#227;o. Cada fator de risco associado (tabagismo, dislipidemia, obesidade, sedentarismo, estresse, &#225;lcool excessivo e diabetes) deve receber a mesma aten&#231;&#227;o.</p>
    <p>O tratamento n&#227;o-medicamentoso &#233; indicado para todos. Quando n&#227;o for suficiente para o controle da press&#227;o, tornar&#225; menor a quantidade da medica&#231;&#227;o necess&#225;ria e far&#225; que os f&#225;rmacos tenham sua a&#231;&#227;o mais efetiva<sup>4-6</sup>.</p>
    <p>Devemos dar aos indiv&#237;duos informa&#231;&#245;es detalhadas sobre cada um dos riscos presentes, sua import&#226;ncia e como fazer para modific&#225;-los.</p>
    <p>O m&#233;todo mais efetivo do abandono do tabagismo &#233; o aconselhamento m&#233;dico, nunca nos esque&#231;amos desse fato<sup>4-6</sup>.</p>
    <p>A orienta&#231;&#227;o sobre uma alimenta&#231;&#227;o com baixo teor de s&#243;dio deve ser simples e clara. Da mesma maneira, ao indicar uma dieta hipolip&#237;dica, hipocal&#243;rica ou hipouric&#234;mica, temos que ser did&#225;ticos e preocupar-nos com detalhes (tipos de alimentos, medidas caseiras, qualidade, hor&#225;rios)<sup>4-13</sup>. E repetir e refor&#231;ar as informa&#231;&#245;es a cada retorno.</p>
    <p>As metas de &#205;ndice de Massa Corp&#243;rea saud&#225;vel devem ser discutidas. A diminui&#231;&#227;o de 10% no peso por etapas, a cada seis a dez meses, torna os resultados mais f&#225;ceis de serem alcan&#231;ados e as frustra&#231;&#245;es, menos evidentes. Atingir essa meta torna o benef&#237;cio bastante significativo<sup>4-7,9,10</sup>.</p>
    <p>A orienta&#231;&#227;o sobre atividade f&#237;sica deve tamb&#233;m ocupar parte de nosso tempo. Refor&#231;ar que todo tipo de movimenta&#231;&#227;o &#233; bem-vindo e indicar a busca do exerc&#237;cio mais prazeroso. A caminhada, em princ&#237;pio, n&#227;o tem contra-indica&#231;&#227;o e deve ser a atividade m&#237;nima recomendada<sup>4-6</sup>.</p>
    <p>As informa&#231;&#245;es sobre as bebidas alco&#243;licas n&#227;o devem ser desprezadas; quantidade, qualidade, periodicidade precisam ser detalhadamente descritas. Assim fica mais f&#225;cil a compreens&#227;o e a aceita&#231;&#227;o<sup>12</sup>.</p>
    <p>O diabetes necessita de controle sem tr&#233;gua. Este controle deve ser rigoroso e cont&#237;nuo. Quanto melhor, maior o benef&#237;cio. Novamente a informa&#231;&#227;o &#233; elemento-chave para o sucesso<sup>4-7,10</sup>.</p>
    <p>O uso de f&#225;rmacos anti-hipertensivos, quando necess&#225;rios (e cada vez s&#227;o mais necess&#225;rios), tamb&#233;m deve ser bastante discutido. Motivos para seu uso, tempo, tipo de medicamento, n&#250;mero de tomadas, hor&#225;rios, necessidade de associa&#231;&#227;o, possibilidade de efeitos adversos e assim por diante. Temos na atualidade uma boa variedade de drogas com muito boa efic&#225;cia e efetividade<sup>4-6,14,15</sup>. S&#227;o praticamente isentas de efeitos colaterais e quando usadas isoladas ou em associa&#231;&#227;o, atendem plenamente &#224;s necessidades de controle da press&#227;o e diminuem a morbidade e mortalidade. &#201; preciso que sejam ingeridas regularmente, de acordo com a recomenda&#231;&#227;o m&#233;dica. Aqui novamente a informa&#231;&#227;o precisa &#233; crucial e o esclarecimento de d&#250;vidas, obrigat&#243;rio. Neste particular, ainda persistem cren&#231;as e hist&#243;rias sobre os medicamentos e devemos ser ativos no rompimento dessas barreiras.</p>
    <p>A continuidade do tratamento &#233; outro ponto que sempre suscita d&#250;vidas e temos de ser incans&#225;veis ao enfatizar e esclarecer esse t&#243;pico.</p>
    <p>Fornecer prescri&#231;&#245;es leg&#237;veis e claras. O que parece estar escrito de maneira intelig&#237;vel para n&#243;s nem sempre o &#233; para o paciente. A preocupa&#231;&#227;o com uma linguagem simples, a anota&#231;&#227;o de hor&#225;rios, a refer&#234;ncia a momentos marcantes (per&#237;odos do dia, refei&#231;&#245;es, sono etc), e novamente a necessidade do uso cont&#237;nuo devem estar detalhados na nossa receita<sup>2,3,5</sup>.</p>
    <p>Finalmente, devem ser estabelecidos retornos de maneira objetiva. A liberalidade na marca&#231;&#227;o das consultas &#233; totalmente prejudicial. Da mesma forma, os retornos em intervalos muito prolongados contribuem para uma piora na ades&#227;o. Cada volta deve ocorrer em per&#237;odo definido (nunca maior que seis meses), preferencialmente com a marca&#231;&#227;o de um dia exato e um contato telef&#244;nico para a confirma&#231;&#227;o<sup>3,4</sup>.</p>
    <p>Os faltosos devem ser alvo de busca ativa, por telefone, telegrama ou carta breve. Esse expediente tem grande efic&#225;cia e refor&#231;a a rela&#231;&#227;o de parceria entre o paciente e o m&#233;dico respons&#225;vel<sup>3-5</sup>.</p>
    <p>Procuramos expressar assim nosso ponto de vista, trazendo aos colegas um pouco de nossa experi&#234;ncia e mostrando a estrat&#233;gia que utilizamos tanto no consult&#243;rio privado quanto nos consult&#243;rios da Liga de Hipertens&#227;o, nesse &#250;ltimo caso facilitado pela presen&#231;a de uma equipe multiprofissional.</p>
    <p>O uso desses m&#233;todos tem propiciado uma melhor ades&#227;o do paciente ao tratamento, permitindo melhor controle de sua press&#227;o arterial e dos fatores de risco associados.</p>
    <p>
      <bold>REFER&#202;NCIAS</bold>
    </p>
    <p>1. Rodrigues Branco RFG Y. A Rela&#231;&#227;o com o Paciente. Teoria, Ensino e Pr&#225;tica. Rio de Janeiro: Guanabara Koogan, 2003, 324p.</p>
    <p>2. Nobre F, Pierin AMG, Mion Jr D. Ades&#227;o ao Tratamento. O Grande Desafio da Hipertens&#227;o. S&#227;o Paulo: Lemos Editorial, 2001: 118p.</p>
    <p>3. Jardim PCBV, Sousa, ALL, Monego ET. Atendimento multiprofissional ao paciente hipertenso. Medicina Ribeir&#227;o Preto, 1996; 29: 232-8.</p>
    <p>4. IV Diretrizes Brasileiras de Hipertens&#227;o Arterial. Arq Bras Cardiol 2004;82(supl. IV):1-40.</p>
    <p>5. Chobanian AV, Bakris GL, Black HR et al. National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.</p>
    <p>6. 2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-23.</p>
    <p>7. Kraus RM, Eckel RH, Howard B. AHA Dietary Guideline. Circulation 2000; 102: 2284-99.</p>
    <p>8. Nakasato M. Sal e hipertens&#227;o arterial. Rev Bras Hipertens 2004; 11: 95-7.</p>
    <p>9. Nonino-Borges CB, dos Santos JE. Terapia nutricional nas altera&#231;&#245;es metab&#243;licas associadas &#224; hipertens&#227;o arterial (diabete melito, dislipidemias, hiperuricemia). Rev Bras Hipertens 2004; 11: 98-101.</p>
    <p>10. Monego ET, Maggi C. Gastronomia na promo&#231;&#227;o da sa&#250;de dos pacientes hipertensos. Rev Bras Hipertens 2004; 11: 105-8.</p>
    <p>11. Jardim PCBV, Monego ET, Reis MAC. Pot&#225;ssio, c&#225;lcio, magn&#233;sio e hipertens&#227;o arterial. Rev Bras Hipertens 2004; 11: 109-11.</p>
    <p>12. Souza WKSB, Amaral GF. &#193;lcool, hipertens&#227;o arterial e doen&#231;a cardiovascular. Rev Bras Hipertens 2004; 11: 112-14.</p>
    <p>13. Grundy SM, Hansen B, Smith Jr. S et al. Clinical Management of Metabolic Syndrome. Circulation 2004; 109: 551-6.</p>
    <p>14. Williams B. Recent Hypertension Trials. Implications and Controversies. J Am Coll Cardiol 2005;45:813-27.</p>
    <p>15. Blood Pressure Lowering Treatment Trialists Collaboration. Effects of different blood pressure-lowering regimes on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003; 362: 1527-45.</p>
    <p>
      <fn id="back10" fn-type="corresp">
        <label>
          <bold>Endere&#231;o para correspond&#234;ncia</bold>
        </label>
        <p> Paulo C&#233;sar B. Veiga Jardim </p>
        <p> Rua 115-F, n.135 </p>
        <p> Setor Sul </p>
        <p> 74085-300 - Goi&#226;nia, GO </p>
        <p> E-mail: </p>
        <p>
          <email xlink:href="fvjardim@terra.com.br">fvjardim@terra.com.br</email>
        </p>
      </fn>
    </p>
    <p> Recebido em 02/05/05 </p>
    <p> Aceito em 04/05/05</p>
  </body>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Points of View</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Treating hypertension in the doctor's office</article-title>
      </title-group>
    </front-stub>
    <body>
      <p>
        <bold>POINT OF VIEW</bold>
      </p>
      <p>Treating hypertension in the doctor's office </p>
      <p>
        <bold>Paulo C&#233;sar B. Veiga Jardim</bold>
      </p>
      <p>Faculdade de Medicina da Universidade Federal de Goi&#225;s - Goi&#226;nia, GO - Brazil</p>
      <p>
        <xref ref-type="corresp" rid="back10-body2">Mailing address</xref>
      </p>
      <p>A visit to the doctor's office by a patient to be informed of or receive a confirmation of a hypertension diagnosis is the opportune time to establish what will hopefully be a lasting relationship, since this is the basis for quality care and a good doctor-patient relationship<sup>1,2</sup>.</p>
      <p>The first step that the doctor must take is to establish an alliance with the patient. The success of any treatment depends on this. This partnership should be established from the beginning and it is up to us, since we are aware of this prerequisite, to maneuver the situation towards this objective<sup>1,2</sup>.</p>
      <p>Knowing how to listen and being always all ears; showing an interest in every detail of this new partner's life; understanding her daily life; learning about her habits, sympathizing with her concerns and anxieties, valueing what she has to say are paths towards this end<sup>1,2</sup>.</p>
      <p>The acceptance of a "disease" is not automatic. This acceptance is much more difficult when the alteration arises in an early stage of life. In most cases there are no symptoms and the treatment will require lifestyle changes.</p>
      <p>The second step is information. It should be clear, simple and repetitive, keeping in mind that we only hear what interests us. Therefore, it is important to repeat and repeat, with different approaches, again and again. A well informed patient is better equipped to assume the treatment. The information is completely our responsibility; it should be verbal, written and visual<sup>1-3</sup>. It should be never ending.</p>
      <p>The third step, just as important as the others mentioned above is availability. There is nothing better than to be within easy reach, the possibility to clarify a doubt, to offer support in a moment of insecurity. A telephone call for support, a quickly accessible reference address and these days an e-mail address<sup>1-6</sup>.</p>
      <p>Hypertension is rarely an isolated condition, it is almost always associated with a number of risk factors. While we investigate the illness, we should begin the negotiation process for the patient to adopt a healthy lifestyle<sup>4-6</sup>. After all, life is made of exchanges.</p>
      <p>Be firm but not inflexible, and keep on negotiating. Know when to push forward and when to back off. We are continually interfering in habits that make up the person's culture and modification requires time. Time, information and negotiation.</p>
      <p>More and more we are convinced that dealing with numbers is not enough; hypertension is much more than that. The more comprehensive our approach the greater the beneficial results will be. Every associated risk factor (smoking, dyslipidemia, obesity, sedentary lifestyle, stress, excessive alcohol consumption and diabetes) should receive the same degree of attention.</p>
      <p>Treatment without the use of drugs is indicated for everyone. When this is not sufficient to control blood pressure, it will help to reduce the required medicine dosage and complement the effectiveness of the drugs<sup>4-6</sup>.</p>
      <p>We should give the patients detailed information about all possible risks, their importance and how to modify them.</p>
      <p>The most effective method to convince a patient to quit smoking is medical advice, we should never forget this fact<sup>4-6</sup>.</p>
      <p>Advice about a low sodium diet should be simple and clear. Similarly, indications for low fat, low calorie or hypouricemic diets, we must be instructive and attentive to details (types of food, portion sizes, quality, hours)<sup>4-13</sup>. Repeat and reinforce the information on every return visit.</p>
      <p>Healthy weight levels according to the Body Mass Index should be discussed. Progressive weight reduction of 10% every six to ten months makes the end result easier to achieve and helps to eliminate frustrations. Meeting this goal brings significant benefits<sup>4-7,9,10</sup>.</p>
      <p>Physical activity counseling should also be addressed during the visit. Reinforce that any type of physical activity is welcome and encourage the person to find a pleasurable exercise. Generally speaking there are no restrictions for anyone to take a walk and should be the minimum level of recommended exercise<sup>4-6</sup>.</p>
      <p>Information regarding alcoholic beverages should not be neglected; quantity, quality and frequency should be described in detail. This facilitates understanding and acceptance<sup>12</sup>.</p>
      <p>Diabetes must be controlled without exceptions. This control should be rigorous and continuous. The better it is, the greater the benefit. Once again, information is the key to success<sup>4-7,10</sup>.</p>
      <p>The use of anti-hypertensive drugs, when required (and they are becoming more and more necessary) should also be discussed in detail. Why they should be used, length of time, type of medicine, number of doses, how often, association requirements, possible adverse effects and so on. There is currently a large variety of drugs available that are efficient and effective<sup>4-6,14,15</sup>. They have practically no collateral effects and when used alone or in association with other medications, effectively control blood pressure and diminish morbidity and mortality. The medicine must be taken regularly, in accordance with the doctor's recommendation. Once again, precise information is crucial and clarification of doubts is mandatory. In relation to this, there are still a number of negative beliefs and old wives tales about drugs and we should be active in overcoming these barriers.</p>
      <p>The continuation of treatment is another point that always raises doubts and we must relentlessly emphasize and clarify this topic.</p>
      <p>Supply prescriptions that are legible and clear. What appears to be intelligible for us is often confusing for the patient. A concern for simple language, notation of hours, reference to significant moments (time of day, meals, rest, etc.) and once again the necessity of continual use should be detailed on our prescription<sup>2,3,5</sup>.</p>
      <p>Finally, return check-ups should be scheduled in an objective manner. The freedom for the patient to schedule appointment regularity is completely detrimental to positive results. Likewise, long durations between return visits contribute to lower adhesion rates. Every return visit should take place within a defined period (never more than six months) preferably scheduled for an exact day with a follow up confirmation by telephone<sup>3,4</sup>.</p>
      <p>Those who miss appointments should be the target of an active search by telephone, telegram or a short letter. This tool is greatly effective and reinforces the partnership relation between the patient and the doctor<sup>3-5</sup>.</p>
      <p>Our intention here was to express our point of view, share a little of our experience with our colleagues and explain the strategy that we use for both private consultations and those conducted at the <italic>Liga de Hipertens&#227;o</italic> clinic, where the process is greatly facilitated by the multi-professional staff.</p>
      <p>The use of these methods has resulted in better treatment adhesion by the patients and subsequently a better control of their blood pressure and associated risk factors.</p>
      <p>
        <bold>REFERENCES</bold>
      </p>
      <p>1. Rodrigues Branco RFG Y. A Rela&#231;&#227;o com o Paciente. Teoria, Ensino e Pr&#225;tica. Rio de Janeiro: Guanabara Koogan, 2003, 324p.</p>
      <p>2. Nobre F, Pierin AMG, Mion Jr D. Ades&#227;o ao Tratamento. O Grande Desafio da Hipertens&#227;o. S&#227;o Paulo: Lemos Editorial, 2001: 118p.</p>
      <p>3. Jardim PCBV, Sousa, ALL, Monego ET. Atendimento multiprofissional ao paciente hipertenso. Medicina Ribeir&#227;o Preto, 1996; 29: 232-8.</p>
      <p>4. IV Diretrizes Brasileiras de Hipertens&#227;o Arterial. Arq Bras Cardiol 2004;82(supl. IV):1-40.</p>
      <p>5. Chobanian AV, Bakris GL, Black HR et al. National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.</p>
      <p>6. 2003 European Society of Hypertension European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-23.</p>
      <p>7. Kraus RM, Eckel RH, Howard B. AHA Dietary Guideline. Circulation 2000; 102: 2284-99.</p>
      <p>8. Nakasato M. Sal e hipertens&#227;o arterial. Rev Bras Hipertens 2004; 11: 95-7.</p>
      <p>9. Nonino-Borges CB, dos Santos JE. Terapia nutricional nas altera&#231;&#245;es metab&#243;licas associadas &#224; hipertens&#227;o arterial (diabete melito, dislipidemias, hiperuricemia). Rev Bras Hipertens 2004; 11: 98-101.</p>
      <p>10. Monego ET, Maggi C. Gastronomia na promo&#231;&#227;o da sa&#250;de dos pacientes hipertensos. Rev Bras Hipertens 2004; 11: 105-8.</p>
      <p>11. Jardim PCBV, Monego ET, Reis MAC. Pot&#225;ssio, c&#225;lcio, magn&#233;sio e hipertens&#227;o arterial. Rev Bras Hipertens 2004; 11: 109-11.</p>
      <p>12. Souza WKSB, Amaral GF. &#193;lcool, hipertens&#227;o arterial e doen&#231;a cardiovascular. Rev Bras Hipertens 2004; 11: 112-14.</p>
      <p>13. Grundy SM, Hansen B, Smith Jr. S et al. Clinical Management of Metabolic Syndrome. Circulation 2004; 109: 551-6.</p>
      <p>14. Williams B. Recent Hypertension Trials. Implications and Controversies. J Am Coll Cardiol 2005;45:813-27.</p>
      <p>15. Blood Pressure Lowering Treatment Trialists Collaboration. Effects of different blood pressure-lowering regimes on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003; 362: 1527-45.</p>
      <p>
        <fn id="back10-body2" fn-type="corresp">
          <p>Mailing address</p>
          <p> Paulo C&#233;sar B. Veiga Jardim </p>
          <p> Rua 115-F, n.135 - Setor Sul</p>
          <p> 74085-300 - Goi&#226;nia, GO - Brazil</p>
          <p> E-mail: </p>
          <p>
            <email xlink:href="fvjardim@terra.com.br">fvjardim@terra.com.br</email>
          </p>
        </fn>
      </p>
      <p>Received on 05/02/05</p>
      <p> Accepted on 05/04/05</p>
    </body>
  </sub-article>
</article>
